Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00629) | |||||
---|---|---|---|---|---|
Name |
Sodium bicarbonate
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
SODIUM BICARBONATE; 144-55-8; Sodium hydrogen carbonate; Sodium hydrogencarbonate; Baking soda; Carbonic acid monosodium salt; Sodium acid carbonate; Bicarbonate of soda; Sodium hydrocarbonate; Meylon; Acidosan; Natriumhydrogenkarbonat; NaHCO3; Monosodium carbonate; Jusonin; Soludal; Soda Mint; Soda (van); Carbonic acid sodium salt (1:1); Sodium bicarbonate (1:1); Monosodium hydrogen carbonate; MFCD00003528; Carbonic acid, monosodium salt; UNII-8MDF5V39QO; 8MDF5V39QO; CHEBI:32139; Natron; Col-evac; Sel De vichy; Natrium bicarbonicum; Soda Ash; Natrii hydrogencarbonas; Natrium hydrogencarbonicum; sodium hydrogen-carbonate; Caswell No. 747; Sodium carbonate (Na(HCO3)); Sodium bicarbonate, 99+%, for HPLC; Sodium bicarbonate, 99+%, extra pure; Sodium bicarbonate, 99.5%, for analysis; Sodium bicarbonate in plastic container; Meylon (TN); Sodium bicarbonate, 99.7+%, ACS reagent; CCRIS 3064; HSDB 697; Sodium bicarbonate, 99.5%, for biochemistry; Neut (TN); NSC-134031; sodium;hydrogen carbonate; EINECS 205-633-8; Sodium bicarbonate solution; EPA Pesticide Chemical Code 073505; NSC 134031; Sodium bicarbonate [USP:JAN]; sodium bicabonate; sodium bicarbonat; bicarbonate sodium; sodiumbi-carbonate; sodium bi-carbonate; sodium bicarbonate-; Sodium bi carbonate; natriumhydrogencarbonat; CHNaO3; sodium hydrogencabonate; sodium hydrogencarbonat; sodiumhydrogen carbonate; PubChem23592; sodium hydrogen cabonate; ACMC-20ajp0; hydrogen carbonate sodium; Sodium bicarbonate, USP; sodium hyd-rogencarbonate; sodium-hydrogen-carbonate; SODIUM BICARBONIATE; EC 205-633-8; CHEMBL1353; INS NO.500(II); DTXSID9021269; INS-500(II); Sodium bicarbonate (JP17/USP); sodium hydrogen carbonate solution; E-500(II); Sodium bicarbonate -40-+140 mesh; Sodium bicarbonate, Biochemical Grade; AKOS015836321; AKOS015951222; Sodium hydrogen carbonate, Puratronic?; DB01390; Sodium bicarbonate A.C.S. reagent grade; Bicarbonate, 1M buffer solution, pH 8.0; Bicarbonate, 1M buffer solution, pH 8.5; FT-0645108; C12603; D01203; 3-Phenyl-2-thioxotetrahydropyrimidin-4(1H)-one; Sodium bicarbonate, 1M buffer solution, pH 8.0; Sodium bicarbonate, 1M buffer solution, pH 9.0; Q179731; Sodium bicarbonate, 1M buffer solution, pH 10.0; Sodium bicarbonate, HPLC, Meets ACS Specifications; Sodium bicarbonate 5% w/v solution in water (+/- 0.3%); Saturated aqueous Sodium bicarbonate solution (~9.6% wt/wt/)
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Metabolic acidosis | ICD-11: 5C73 | [1] | ||
PubChem CID | |||||
Formula |
CHNaO3
|
||||
Canonical SMILES |
C(=O)(O)[O-].[Na+]
|
||||
InChI |
1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1
|
||||
InChIKey |
UIIMBOGNXHQVGW-UHFFFAOYSA-M
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=516892"></iframe>
|
||||
3D MOL is unavailable | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 84.007 | Topological Polar Surface Area | 60.4 | |
XlogP | N.A. | Complexity | 33.9 | ||
Heavy Atom Count | 5 | Rotatable Bond Count | 0 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Sodium bicarbonate 325 mg tablet | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Talc; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Richmond Pharmaceuticals; Rugby Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rugby Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Reliable 1 Laboratires | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Sodium bicarbonate 650 mg tablet | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Talc; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rugby Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Talc; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rising Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rugby Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health; Gericare Pharmaceuticals; Reliable 1 Laboratires | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Croscarmellose sodium; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aphena Pharma Solutions-Tennessee; Richmond Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.